Roderik Kraaijenhagen
Amministratore Delegato presso Qurin Diagnostics BV
Provenienza dei contatti di primo grado di Roderik Kraaijenhagen
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Niped Prevention BV
 Niped Prevention BV Internet Software/ServicesTechnology Services Niped Prevention BV provides e-health platform for personal prevention. It specializes in risk profiling, intervention matching, self-management, health check, health profile, matching health, lifestyle, preventive medical examination, health report and research. The company was founded by Coenraad van Kalken in 2005 and is headquartered in Amsterdam, the Netherlands.
2
| Holding Company | Internet Software/Services | 2 |
Qurin Diagnostics BV
 Qurin Diagnostics BV BiotechnologyHealth Technology Qurin Diagnostics BV develops diagnostic devices to non invasively detect early stage cancer of multiple types. The company was founded by Roderik Kraaijenhagen and is headquartered in Enschede, the Netherlands.
2
| Holding Company | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Roderik Kraaijenhagen tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Leiden | College/University | Undergraduate Degree | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Medical/Nursing Services | Chief Operating Officer | |
Gedi Cube Intl Ltd.
 Gedi Cube Intl Ltd. Medical/Nursing ServicesHealth Services Part of Renovaro, Inc., Renovaro Cube Intl Ltd. is a British company that provides cancer diagnostics and monitoring of treatment services. The company is based in London, UK. The company was founded in 2023. The CEO is Coenraad K. van Kalken. Renovaro Cube Intl was acquired by Renovaro, Inc. on February 13, 2024. | Medical/Nursing Services | Chief Executive Officer | |
| NEDERLANDSE BELEGGINGSMAATSCHAPPIJ VOOR ZEESCHEPEN BV | Investment Trusts/Mutual Funds | Director/Board Member |
Statistiche
Distribuzione geografica
| Paesi Bassi | 6 |
| Regno Unito | 2 |
Settori
| Health Services | 3 |
| Electronic Technology | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
| Miscellaneous | 2 |
Posizioni
| Chief Operating Officer | 3 |
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Contatti più connessi
- Borsa valori
- Insiders
- Roderik Kraaijenhagen
- Connessioni Società
